2,030
Views
8
CrossRef citations to date
0
Altmetric
Articles

How do EQ-5D-3L and EQ-5D-5L compare in a Swedish total hip replacement population?

, , , &

  • Anakwe R E, Jenkins P J, Moran M. Predicting dissatisfaction after total hip arthroplasty: a study of 850 patients. J Arthroplasty 2011; 26(2): 209–13.
  • Bland J M, Altman D G. Statistical methods for assessing agreement between two methods of clinical measurement. Int J Nurs Stud 2010; 47(8): 931–6.
  • Buchholz I, Janssen M F, Kohlmann T, Feng Y-S. A systematic review of studies comparing the measurement properties of the three-level and five-level versions of the EQ-5D. PharmacoEconomics 2018; 36(6):645–66.
  • Burstrom K, Sun S, Gerdtham U-G, Henriksson M, Johannesson M, Levin L-A, Zethraeus N. Swedish experience-based value sets for EQ-5D health states (Report) (Author abstract). Qual Life Res 2014; 23(2): 431.
  • Clement N D, Muzammil A, Macdonald D, Howie C R, Biant L C. Socioeconomic status affects the early outcome of total hip replacement. J Bone Joint Surg Br 2011; 93(4): 464.
  • Conner-Spady B L, Marshall D A, Bohm E, Dunbar M J, Loucks L, Al Khudairy A, Noseworthy T W. Reliability and validity of the EQ-5D-5L compared to the EQ-5D-3L in patients with osteoarthritis referred for hip and knee replacement. Qual Life Res 2015; 24(7): 1775–84.
  • Craig B M, Pickard A S, Lubetkin E I. More common, but less severe: differences between EQ-5D 3-level, youth, and 5-level versions. J Clin Epidemiol 2014; 67(1): 93–9.
  • Devlin N J, Parkin D, Browne J. Patient–reported outcome measures in the NHS: new methods for analysing and reporting EQ–5D data. Health Econ 2010; 19(8): 886–905.
  • Devlin N J, Krabbe P F M. The development of new research methods for the valuation of EQ-5D-5L. Eur J Health Econ 2013; 14(Suppl 1): S1.
  • Devlin N J, Shah K K, Feng Y, Mulhern B, van Hout B. Valuing health-related quality of life: an EQ-5D-5L value set for England. Health Econ 2018; 27(1): 7–22.
  • Golicki D, Niewada M, Buczek J, KarliAska A, Kobayashi A, Janssen M F, Pickard A S. Validity of EQ-5D-5L in stroke. Qual Life Res 2015; 24(4): 845.
  • Greene M E, Rader K A, Garellick G, Malchau H, Freiberg A A, Rolfson O. The EQ-5D-5L improves on the EQ-5D-3L for health-related quality-of-life assessment in patients undergoing total hip arthroplasty. Clin Orthop Relat Res 2015; 473(11): 3383.
  • Herdman M, Gudex C, Lloyd A, Janssen M, Kind P, Parkin D, Bonsel G, Badia X. Development and preliminary testing of the new five-level version of EQ-5D (EQ-5D-5L). Qual Life Res 2011; 20(10): 1727.
  • Hinz A, Kohlmann T, Stöbel-Richter Y, Zenger M, Brähler E. The quality of life questionnaire EQ-5D-5L: psychometric properties and normative values for the general German population. Qual Life Res 2014; 23(2): 443–7.
  • Janssen M F, Birnie E, Haagsma J A, Bonsel G J. Comparing the standard EQ–5D three–level system with a five–level version. Value Health 2008; 11(2): 275–84.
  • Janssen M F, Pickard A S, Golicki D, Gudex C, Niewada M, Scalone L, Swinburn P, Busschbach J. Measurement properties of the EQ-5D-5L compared to the EQ-5D-3L across eight patient groups: a multi-country study. Qual Life Res 2013; 22(7): 1717.
  • Kärrholm J, Mohaddes M, Odin D, Vinblad J, Rogmark C, Rolfson O. The Swedish Hip Arthroplasty Register Annual Report 2017 [Internet]. The Swedish Hip Arthroplasty Register; 2018. Available from: http://refdocs.registercentrum.se/10.18158/BkOffx7U4
  • Lawless B, Greene M, Slover J, Kwon Y-M, Malchau H. Does age or bilateral disease influence the value of hip arthroplasty? Clin Orthop Relat Res 2012; 470(4): 1073–8.
  • Leidl R, Reitmeir P. An experience-based value set for the EQ-5D-5L in Germany. Value Health 2017; 20(8): 1150–6.
  • Lim C R, Harris K, Dawson J, Beard D J, Fitzpatrick R, Price A J. Floor and ceiling effects in the OHS: an analysis of the NHS PROMs data set. BMJ Open 2015; 5(7): e007765.
  • LROI. Annual report Dutch Arthroplasty Register. [Annual report]; 2016.
  • Myers J L, Well A D. Research design and statistical analysis, 2nd ed. Mahwah, NJ: Lawrence Erlbaum; 2003. p 508.
  • Oppe M, Devlin N J, van Hout B, Krabbe P F, de Charro F. A program of methodological research to arrive at the new international EQ-5D-5L valuation protocol. Value Health 2014; 17(4) (445–453).
  • Pickard S A, De Leon C M, Kohlmann C T, Cella C D, Rosenbloom C S. Psychometric comparison of the standard EQ-5D to a 5 level version in cancer patients. Med Care 2007; 45(3): 259–63.
  • Rabin R, Charro F D. EQ-SD: a measure of health status from the EuroQol Group. Ann Med 2001; 33(5): 337–43.
  • Rolfson O, Karrholm J, Dahlberg L E, Garellick G. Patient-reported outcomes in the Swedish Hip Arthroplasty Register: results of a nationwide prospective observational study. J Bone Joint Surg Br 2011; 93(7): 867–75.
  • Scalone L, Ciampichini R, Fagiuoli S, Gardini I, Fusco F, Gaeta L, Del Prete A, Cesana G, Mantovani L G. Comparing the performance of the standard EQ-5D 3L with the new version EQ-5D 5L in patients with chronic hepatic diseases. Qual Life Res 2013; 22(7): 1707–16.
  • Sullivan W P, Lawrence F W, Ghushchyan F V. A national catalog of preference-based scores for chronic conditions in the United States. Med Care 2005; 43(7): 736–49.
  • Wolfe F, Hawley D J. Measurement of the quality of life in rheumatic disorders using the EuroQol. Rheumatol 1997; 36(7): 786–93.rheumatology/36.7.786.